Telangana: 19th Edition Of BioAsia To Start From Feb 24 In Hyderabad

The annual flagship event of the Government of Telangana has always featured participation from prominent leaders from the life sciences and healthcare industry over the past 18 editions. 

Telangana: 19th Edition Of BioAsia To Start From Feb 24 In Hyderabad (Image: Twitter)

Hyderabad: BioAsia, the largest annual global Biotechnology and Life Sciences convention of Asia, starting on February 24, will feature an insightful session with Bill Gates, co-founder of Bill & Melinda Gates Foundation.

The annual flagship event of the Government of Telangana has always featured participation from prominent leaders from the life sciences and healthcare industry over the past 18 editions. 

The highlight of the 2022 edition will be a fireside chat between KT Rama Rao, Minister for Industries & Commerce, IT & MAUD and Bill Gates, around a range of themes, including the Covid-19 pandemic, learnings during the past two years, emerging healthcare trends and what can be done to strengthen the global healthcare system going forward. 

Bill Gates is known for his incredible philanthropic contributions and a keen interest in technology, sciences, and emerging challenges such as climate change. With this year’s theme being ‘Future Ready,’ the focus of the chat will be on the new approaches and capabilities that can equip the world to be prepared and the role of stakeholders, including government, industry, among others.

Going live on the 24th and 25th February, the 19th virtual edition will also witness a stellar lineup of speakers, including Mr. Alex Gorsky, Executive Chairman of the world’s largest healthcare company, Johnson & Johnson, who would deliver a keynote address during the event.

KT Rama Rao said, "Every edition of BioAsia brings in a cognoscenti participation of global leaders under one tent discussing on important challenges in healthcare. Building on its impressive reputation, I am delighted that the 2022 edition will feature some of the most influential and visionary leaders. I look forward to an interesting session with Mr. Gates to assess the industry’s current position and determine the roadmap ahead. The delegates of BioAsia across the world would also benefit by listening to Mr. Gorsky and Mr. Martha, who come with immense knowledge around the global life sciences industry.”